We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Nabi And Roxane In Patent Dispute Over Kidney Dialysis Drug

Law360 (September 29, 2005, 12:00 AM EDT) -- Nabi Biopharmaceuticals has sued to Roxane Laboratories to prevent the company from making a generic version of kidney dialysis drug PhosLo.

Roxane sent Nabi a letter on August 8, 2005 informing the drug company that it filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration to make a generic version of PhosLo.

The lawsuit claims that “the letter did not provide the information specified by the FDA regulations. Nor did it demonstrate that the ‘665 patent is either invalid or would...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.